Table 2.
Extended Hippurate Analogs as Substrates
| Name | Structure
|
KM,app (mM) | VM,app (s−1) | (V/K)app (M−1 s−1) | Rel. (V/K)app |
|---|---|---|---|---|---|
| 3-(2-Furyl)acryloylglycine (26) |
|
1.2 ± 0.1 | 3.4 ± 0.1 | (2.8 ± 0.1) × 103 | 0.45 |
| N-(α-Methylhydrocinnamoyl) glycine (27) | R = (C6H5)CH2CH(CH3) | 4.1 ± 0.3 | 18 ± 0.9 | (4.3 ± 0.1) × 103 | 0.69 |
| Acetyl-Gly-Gly (28) | R = CH3CONHCH2 | 1.5 ± 0.070 | 8.9 ± 0.2 | (5.9 ± 0.2) × 103 | 1.0 |
| Hippuric acid (1) | R = C6H5 | 1.3 ± 0.04 | 8.2 ± 0.08 | (6.2 ± 0.1) × 103 | 1.0 |
| 2-Propylmercaptoacetylglycine(29) | R = (CH3)2CHSCH2 | 0.22 ± 0.01 | 1.8 ± 0.02 | (8.2 ± 0.3) × 103 | 1.3 |
| N-[(2-Phenylcyclopropyl)carbonyl] glycine (30) |
|
0.90 ± 0.07 | 10 ± 0.3 | (1.1 ± 0.07) × 104 | 1.8 |
| Hydrocinnamoylglycinea (31) | R = (C6H5)CH2CH2 | 0.94 ± 0.1 0.55 ± 0.039 |
9.9 ± 0.4 | (1.1 ± 0.06) × 104 | 1.8 |
| N-[(Benzylmercapto)carbonyl] glycine (32) | R = (C6H5)CH2S | 0.059 ± 0.0070 | 0.69 ± 0.022 | (1.2 ± 0.14) × 104 | 1.9 |
| CBZ-glycine (33) | R = (C6H5)CH2O | 0.59 ± 0.02 | 8.6 ± 0.1 | (1.5 ± 0.03) × 104 | 2.4 |
| Chloroacetyl-Gly-Gly (34) | R = ClCH2CONHCH2 | 0.42 ± 0.03 | 8.9 ± 0.2 | (2.1± 0.1) × 104 | 3.3 |
| Isocaproylglycine (35) | R = (CH3)2CHCH2CH2 | 0.28 ± 0.03 | 6.6 ± 0.3 | (2.3 ± 0.2) × 104 | 3.7 |
| tBOC-Gly-Gly (36) | R = (CH3)3COCONHCH2 | 0.30 ± 0.03 | 7.5 ± 0.2 | (2.5 ± 0.1) × 104 | 4.0 |
| Phenylmercaptoacetylglycin (37) | R = (C6H5)SCH2 | 0.19 ± 0.02 | 4.6 ± 0.2 | (2.5 ± 0.1) × 104 | 4.0 |
| Phenylhydantoic acida (38) | R = (C6H5)NH | 0.36 ± 0.08 0.45 ± 0.05 |
9.7 ± 0.9 | (2.7 ± 0.4) × 104 | 4.4 |
| Hippuryl-Gly-Gly (39) | R = (C6H5)CONHCH2-CONHCH2 | 0.31 ± 0.06 | 8.8 ± 1.3 | (2.9 ± 0.2) × 104 | 4.7 |
| Cinnamoylglycine (40) | R = (C6H5)CH=CH | 0.23 ± 0.02 | 8.4 ± 0.3 | (3.6 ± 0.3) × 104 | 5.8 |
| 3-Phenylthiopropionylglycinea (41) |
|
0.038 ± 0.02 0.023 ± 0.002 |
1.6 ± 0.2 | (4.2 ± 1.4) × 104 | 6.8 |
| Phenaceturic acid (42) | R = (C6H5)CH2 | 0.16 ± 0.005 | 7.4 ± 0.09 | (4.6 ± 0.09) × 104 | 7.4 |
| 4-Phenylbutyrylglycine (43) | R = C6H5(CH2)3 | 0.16 ± 0.02 | 11 ± 0.4 | (7.0 ± 0.7) × 104 | 11 |
| 4-Nitrobenzoyl-Gly-Gly (44) | R = O2NC6H4CONHCH2 | 0.11 ± 0.007 | 8.7 ± 0.2 | (7.6 ± 0.4) × 104 | 12 |
| 5-Phenylpentanoylglycine (45) | R = C6H5(CH2)4 | 0.15 ± 0.01 | 12 ± 0.4 | (7.6 ± 0.4) × 104 | 12 |
| 8-Phenyloctanoylglycinea (46) | R = C6H5(CH2)7 | 0.10 ± 0.009 0.064 ± 0.006 |
8.0 ± 0.3 | (7.6 ± 0.4) × 104 | 12 |
| 2-Pyridylmercaptoacetylglycine (47) |
|
0.036 ± 0.004 | 3.0 ± 0.1 | (8.3 ± 0.7) × 104 | 13 |
| Phenylthioacetylglycineb (48) |
|
0.024 ± 0.005 | 2.4 ± 0.2 | (1.0 ± 0.2) × 105 | 16 |
| Hippuryl-Gly (49) | R = (C6H5)CONHCH2 | 0.078 ± 0.011 | 12 ± 0.8 | (1.6 ± 0.1) × 105 | 26 |
| 6-Phenylhexanoylglycinea (50) | R = C6H5(CH2)5 | 0.051 ± 0.007 0.043 ± 0.005 |
11 ± 0.4 | (2.0 ± 0.2) × 105 | 32 |
Inhibition of N-dansyl-Tyr-Val-Gly amidation yields the Ki,s value shown in italics.
Substrate inhibition observed for this compound, Ki = 3.8 ± 1.3 mM